全文获取类型
收费全文 | 56275篇 |
免费 | 5301篇 |
国内免费 | 4642篇 |
专业分类
耳鼻咽喉 | 556篇 |
儿科学 | 510篇 |
妇产科学 | 527篇 |
基础医学 | 6515篇 |
口腔科学 | 826篇 |
临床医学 | 7840篇 |
内科学 | 8090篇 |
皮肤病学 | 456篇 |
神经病学 | 2990篇 |
特种医学 | 2146篇 |
外国民族医学 | 44篇 |
外科学 | 5423篇 |
综合类 | 10176篇 |
现状与发展 | 7篇 |
一般理论 | 5篇 |
预防医学 | 3833篇 |
眼科学 | 1419篇 |
药学 | 6252篇 |
64篇 | |
中国医学 | 3599篇 |
肿瘤学 | 4940篇 |
出版年
2024年 | 184篇 |
2023年 | 919篇 |
2022年 | 2359篇 |
2021年 | 2819篇 |
2020年 | 2194篇 |
2019年 | 1925篇 |
2018年 | 2021篇 |
2017年 | 1777篇 |
2016年 | 1737篇 |
2015年 | 2707篇 |
2014年 | 3129篇 |
2013年 | 2650篇 |
2012年 | 4045篇 |
2011年 | 4365篇 |
2010年 | 2794篇 |
2009年 | 2109篇 |
2008年 | 2785篇 |
2007年 | 2873篇 |
2006年 | 2910篇 |
2005年 | 2711篇 |
2004年 | 2063篇 |
2003年 | 2283篇 |
2002年 | 2006篇 |
2001年 | 1746篇 |
2000年 | 1498篇 |
1999年 | 1402篇 |
1998年 | 1020篇 |
1997年 | 929篇 |
1996年 | 673篇 |
1995年 | 689篇 |
1994年 | 597篇 |
1993年 | 300篇 |
1992年 | 399篇 |
1991年 | 336篇 |
1990年 | 265篇 |
1989年 | 265篇 |
1988年 | 192篇 |
1987年 | 153篇 |
1986年 | 128篇 |
1985年 | 96篇 |
1984年 | 44篇 |
1983年 | 36篇 |
1982年 | 25篇 |
1981年 | 25篇 |
1980年 | 19篇 |
1979年 | 12篇 |
1978年 | 2篇 |
1977年 | 1篇 |
1976年 | 1篇 |
排序方式: 共有10000条查询结果,搜索用时 12 毫秒
91.
92.
Xu Li Siming Li Zhihong Chi Chuanliang Cui Lu Si Xieqiao Yan Lili Mao Bin Lian Bixia Tang Xuan Wang Xue Bai Li Zhou Yan Kong Jie Dai Jun Guo Xinan Sheng 《Urologic oncology》2021,39(1):75.e1-75.e8
PurposeTo investigate the clinical characteristics, chemosensitivity, and outcome of metastatic upper tract urothelial carcinoma (UTUC).Patients and MethodsRecords of patients with metastatic UTUC since January 2005 were retrieved from a database that included clinical and survival data. Statistical analyses including survival and multivariate analyses of factors were respectively performed by the Kaplan-Meier method and Cox proportional hazard model.ResultsA total of 250 consecutive UTUC cases were evaluated. There were 56 patients (22.4%) with initially diagnosed stage IV disease. The most common metastatic sites were lung (39.6%), distant lymph nodes (39.2%), bone (19.6%), liver (18.0%), and adrenal gland (7.2%), respectively, and the local recurrence rate was 10.4%. Two hundred thirteen patients received first-line chemotherapy. The overall response rate was only 28.7% and the median progression-free survival time was only 5.0 months. The overall survival time of the cohort was 18.0 months. Multivariate analyses showed that initially diagnosed stage IV disease, number of metastatic organs ≥3, no response to chemotherapy and cycles of chemotherapy ≤2 were adverse prognosticators for overall survival.ConclusionUTUC presented to be more prone to metastasize than locally recur and thought to have low chemosensitivity. Stage IV disease at initial diagnosis, number of metastatic organs, response and cycles of chemotherapy were independent prognosticators for metastatic UTUC. 相似文献
93.
Zhenlang Guo Chiming Gu Siyi Li Shu Gan Yuan Li Songtao Xiang Leiliang Gong Shusheng Wang 《Urologic oncology》2021,39(3):171-179
Background: Patients with bladder cancer have a high risk of suicide. This study aimed to assess how bladder cancer increases suicide risk and to identify the demographic and clinical factors associated with suicidal death among patients with bladder cancer. Methods: Literature search of MEDLINE, PsycINFO, Embase, Web of Sciences and Cochrane Library databases was conducted up to April 2020 to identify eligible studies related to the incidence and risk factors of suicide after bladder cancer diagnosis. Summary multivariate-adjusted risk estimates and their associated 95% confidence intervals (CIs) were calculated using inverse variance method with random or fixed-effect modeling. Results: Five retrospective cohorts comprising 563,680 patients with bladder cancer were included. Higher risk of suicide by 1.90-fold was observed among patients with bladder cancer (hazard ratio, HR = 1.90, 95% CI: 1.29–2.81; P = 0.001; I2 = 81.2%), especially in those aged 70 years or older (HR = 1.36, 95% CI: 1.29–1.43; P < 0.001; I2 = 0%), unmarried (HR = 1.72, 95% CI: 1.61–1.83; P < 0.001; I2 = 0%), and those with regional bladder cancer (HR = 1.88, 95% CI: 1.10–3.21; P = 0.021; I2 = 96.3%), compared with those without bladder cancer. Furthermore, gender and race were not associated with increased suicide risk among patients with bladder cancer. Conclusions: Suicide risk is increased among patients with bladder cancer, particularly those aged 70 years or older, unmarried and those with regional bladder cancer. Hence, early psychological support must be provided during the follow-up period of these special populations with a high suicide risk. 相似文献
94.
Zhang Junjun Wang Yongli Liu Zhangsuo Huang Bo Wang Xutong Xie Minhua Yu Dan Guo Ruxue Wang Panfei 《Clinical and experimental nephrology》2021,25(8):865-874
Clinical and Experimental Nephrology - In this study, we investigated the clinical and pathologic characteristics and prognosis of overlapping obesity-related glomerulopathy (ORG) and... 相似文献
95.
Ran Wei Chiao Yee Lim Yi Yang Xiaodong Tang Taiqiang Yan Rongli Yang Wei Guo 《Orthopaedic Surgery》2021,13(2):553
ObjectivesThis study aims to: (i) evaluate the outcome of patients with Harrington class III lesions who were treated according to Harrington classification; (ii) propose a modified surgical classification for Harrington class III lesions; and (iii) assess the efficiency of the proposed modified classification.MethodsThis study composes two phases. During phase 1 (2006 to 2011), the clinical data of 16 patients with Harrington class III lesions who were treated by intralesional excision followed by reconstruction of antegrade/retrograde Steinmann pins/screws with cemented total hip arthroplasty (Harrington/modified Harrington procedure) were retrospectively reviewed and further analyzed synthetically to design a modified surgical classification system. In phase 2 (2013 to 2019), 62 patients with Harrington class III lesions were classified and surgically treated according to our modified classification. Functional outcome was assessed using the Musculoskeletal Tumor Society (MSTS) 93 scoring system. The outcome of local control was described using 2‐year recurrence‐free survival (RFS). Owing to the limited sample size, we considered P < 0.1 as significant.ResultsIn phase 1, the mean surgical time was 273.1 (180 to 390) min and the mean intraoperative hemorrhage was 2425.0 (400.0 to 8000.0) mL, respectively. The mean follow‐up time was 18.5 (2 to 54) months. Recurrence was found in 4 patients and the 2‐year RFS rate was 62.4% (95% confidence interval [CI] 31.6% to 93.2%). The mean postoperative MSTS93 score was 56.5% (20% to 90%). Based on the periacetabular bone destruction, we categorized the lesions into two subgroups: with the bone destruction distal to or around the inferior border of the sacroiliac joint (IIIa) and the bone destruction extended proximal to inferior border of the sacroiliac joint (IIIb). Six patients with IIIb lesions had significant prolonged surgical time (313.3 vs 249.0 min, P = 0.022), massive intraoperative hemorrhage (3533.3 vs 1760.0 mL, P = 0.093), poor functional outcome (46.7% vs 62.3%, P = 0.093), and unfavorable local control (31.3% vs 80.0%, P = 0.037) compared to the 10 patients with IIIa lesions. We then modified the surgical strategy for two subgroup of class III lesions: Harrington/modified Harrington procedure for IIIa lesions and en bloc resection followed by modular hemipelvic endoprosthesis replacement for IIIb lesions. Using the proposed modified surgical classification, 62 patients in the phase 2 study demonstrated improved surgical time (245.3 min, P = 0.086), intraoperative hemorrhage (1466.0 mL, P = 0.092), postoperative MSTS 93 scores (65.3%, P = 0.067), and 2‐year RFS rate (91.3%, P = 0.002) during a mean follow‐up time of 19.9 (1 to 60) months compared to those in the phase 1 study.ConclusionThe Harrington surgical classification is insufficient for class III lesions. We proposed modification of the classification for Harrington class III lesions by adding two subgroups and corresponding surgical strategies according to the involvement of bone destruction. Our proposed modified classification showed significant improvement in functional outcome and local control, along with acceptable surgical complexity in surgical management for Harrington class III lesions. 相似文献
96.
Jue Chen MD PhD Lei Guo MM Lian Gu MPsy Hui Han MPsy 《The International journal of eating disorders》2021,54(1):102-106
In the past 40 years, the prevalence of eating disorders (ED) in China has shown an increasing trend, leading to an urgent need to develop efficient treatment modes and methods. Since the beginning of the new century, the diagnosis, treatment, and research of ED in China have been under development. This article gives an introduction and commentary on the treatment modes, treatment methods and their applications in ED in China. There are two main treatment forms for ED until now, that is, inpatient treatment and outpatient treatment. Inpatient treatment is recommended as the first choice. Since 2008, clinical psychotherapies such as cognitive behavioral therapy (CBT), dialectical behavioral therapy (DBT), and family-based treatment (FBT), which are effective for pathological symptoms of ED, have been introduced into China and developed clinically. Group CBT and group DBT for patients with ED and group FBT for caregivers might be the most efficient psychotherapy in China nowadays. A multi-family FBT support group could be developed as the basic treatment of ED patients. Although these new types of psychotherapy have observed effectiveness in clinical application, the Randomized Controlled Trials (RCT) are rare and need to be developed. 相似文献
97.
98.
利用二氧化硅特异地吸附核素的特性,建立了从琼脂糖凝胶中回收DNA的方法。结果表明本方法对1300 ̄3500bp的DNA回收效果较好,回收效率达60% ̄70%,100 ̄1500bp,3500 ̄5000bp的DNA亦能被有效地回收。通过对回收DNA的酶切,连接等实验,证实了所回收的DNA片段能够满足进一步的实验要求。该方法简单,快捷,经济,适用,值得推广。 相似文献
99.
淋巴因子激活的NK细胞杀伤肿瘤细胞的免疫电镜观察 总被引:3,自引:0,他引:3
用胶体金标记的扫描与透射免疫电镜术观察CD16^+淋巴因子激活的杀伤细胞杀伤肺腺癌细胞系LTEPa2或人红白血病细胞K562的过程。发现CD16^+LAK细胞能伸出分支的指状突起较深地插入肿瘤细胞浆内,造成靶细胞表面大小深浅不等的隐窝,及陷窝内局部细胞膜损伤,在CD16^+LAK细胞这种指状突起基底部附近的浆内,有大量胞浆颗粒与囊泡聚集。靶细胞被攻击后常发生凋落型死亡。同时可见坏死型死亡。说明CD 相似文献
100.